Results for this period
Third quarter1 October 2025 to 30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
The acquisition of new customers based on recurring revenue from existing customers, growth in platform services and customized development for large customers, and increased usage, new store openings and lower store operating costs in the healthy life expectancy extension business. Meanwhile, in the solutions development business, engineer allocation was reviewed to strengthen AI services, and costs for certain projects were front-loaded.
None ("There are no applicable matters.")
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 October 2025 to 30 June 2026 |
| Net Sales | ¥4,627 million (YoY +15.2%) |
| Operating profit | ¥1,504 million (YoY +29.5%) |
| Ordinary income | ¥1,519 million (YoY +30.7%) |
| Profit attributable to owners of the parent | ¥1,016 million (YoY +27.5%) |
| Net income per share | ¥21.42 |
| Equity ratio | End of the current fiscal period 72.2 / End of previous period 71.1 |
| Total assets | ¥7,429 million |
| Net assets | ¥5,365 million |
| Full-year earnings forecast | Net Sales ¥6,350 million (YoY +15.4%) / Operating profit ¥2,050 million (YoY +27.5%) / Ordinary income ¥2,050 million (YoY +27.1%) / Net income ¥1,370 million (YoY +23.3%) |
| Annual Dividend Forecast | ¥7.5 → ¥9（+20.0%） |
| Segment revenue | Segment Medical and Nursing Care Cloud Platform Business / Net Sales ¥3,070,541 thousand / Year on year against the same period last year 15.7, Segment Healthy Life Expectancy Extension Business / Net Sales ¥1,050,315 thousand / Year on year against the same period last year 26.2, Segment Solutions Development Business / Net Sales ¥506,592 thousand / Year on year against the same period last year -4.6 |
| Segment profit | Segment Medical and Nursing Care Cloud Platform Business / Segment profit ¥1,414,800 thousand / Year on year against the same period last year 27.8, Segment Healthy Life Expectancy Extension Business / Segment profit ¥166,166 thousand / Year on year against the same period last year 85.6, Segment Solutions Development Business / Segment profit ¥-2,141 thousand / Year on year against the same period last year Not disclosed |
| Depreciation and amortization | ¥258,155 thousand |
| Disclosure regarding the going concern assumption | None ("There are no applicable matters.") |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Name of newly added company Not disclosed / Excluded 0 companies / Excluded Company Name Not disclosed |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 48,132,000 |
| Treasury Shares at Period-End | 674,706 |
| Factors Behind Changes in Business Performance | The acquisition of new customers based on recurring revenue from existing customers, growth in platform services and customized development for large customers, and increased usage, new store openings and lower store operating costs in the healthy life expectancy extension business. Meanwhile, in the solutions development business, engineer allocation was reviewed to strengthen AI services, and costs for certain projects were front-loaded. |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the medical and nursing care cloud platform business, the company acquired new customers based on recurring revenue from existing customers, while platform services and customized development for large customers also expanded. In the healthy life expectancy extension business, higher usage at existing stores, new store openings and increased franchise sales, together with lower store operating costs, contributed to profit. Meanwhile, the solutions development business reported lower revenue and profit due to a review of engineer allocation to strengthen AI services and front-loaded costs for certain projects.